Biomarkers may predict Zika-related birth defects
Researchers have identified biomarkers associated with severe birth defects in babies born to women infected with the Zika virus...
List view / Grid view
Researchers have identified biomarkers associated with severe birth defects in babies born to women infected with the Zika virus...
Researchers are developing methos to decrease the body size and weight of mosquitoes in order to control the spread of dengue and Zika...
VSV acted as a vehicle to deliver the genes of some proteins from the Zika virus into mouse models, leading to immunity build up in the mice...
A new generation DNA-based Zika vaccine is the first to demonstrate both safety and the ability to elicit an immune response against Zika in humans...
Scientists have used PET imaging to study brain inflammation following Zika virus infection in mice, allowing investigators to study the progression of the disease over time...
Researchers have used proteomics to examine proteins and peptides in saliva to accurately detect exposure to Zika virus...
Scientists studying cellular enzyme complexes have unexpectedly found that inhibiting EZH2/1 suppressed viral infection in the herpes simplex virus infection...
The research, using tumour cells in the laboratory and in mice, will see if the Zika virus can destroy cancer cells.
New research provides insights into why infection with Zika virus after birth generally causes only mild symptoms, whereas devastating foetal malformations can develop when infection occurs during pregnancy.
The Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito, is an impending threat to America’s borders, with over 5000 cases now reported in the continental US. Zika virus infection has been associated with Guillain-Barré Syndrome, and infection during pregnancy has been…
The research group will explore novel approaches to vaccine development, focusing on the Zika virus.
A new study by scientists at the University of Maryland School of Medicine have identified seven key proteins in the virus that may be the culprits behind its damaging effects.
7 September 2016 | By Niamh Louise Marriott, Digital Content Producer
HSRx expects to begin human trials early in 2017 and will seek accelerated drug approval from the U.S. Food & Drug Administration...
6 July 2016 | By Victoria White, Digital Content Producer
Sanofi Pasteur has signed a Cooperative Research and Development Agreement with the WRAIR on the co-development of a Zika vaccine candidate...
5 July 2016 | By Victoria White, Digital Content Producer
The study aims to improve understanding of how the Zika virus persists in the body and to identify potential factors that influence the course of infection...